Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
299.15
283.23
133.68
239.47
308.33
214.97
119.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
299.15
283.23
133.68
239.47
308.33
214.97
119.50
Raw Material Cost
105.01
140.20
80.21
98.61
148.54
119.93
68.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
23.28
24.96
22.57
25.27
25.25
27.07
26.28
Selling and Distribution Expenses
47.85
58.20
55.63
26.71
45.36
70.53
37.14
Other Expenses
0.76
2.86
0.56
-0.73
-1.07
-0.17
-1.12
Total Expenditure (Excl Depreciation)
183.73
251.97
163.97
143.31
208.47
215.81
120.26
Operating Profit (PBDIT) excl Other Income
115.39999999999999
31.299999999999997
-30.299999999999997
96.19999999999999
99.9
-0.8
-0.8
Other Income
2.01
0.92
-11.25
16.19
4.54
7.89
6.68
Operating Profit (PBDIT)
113.24
40.53
-15.12
142.65
135.14
-70.21
42.03
Interest
23.28
24.96
22.57
25.27
25.25
27.07
26.28
Exceptional Items
-0.05
-0.00
-0.06
0.22
-0.00
0.00
0.00
Gross Profit (PBDT)
194.13
143.03
53.47
140.87
159.79
95.05
51.47
Depreciation
0.00
36.39
36.39
33.13
33.13
39.18
39.18
Profit Before Tax
89.91
-20.81
-74.13
84.48
76.76
-136.47
-23.43
Tax
9.50
12.35
2.41
8.53
6.91
9.44
1.08
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
127.81
-34.78
-74.12
75.60
69.87
-138.85
-24.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
127.81
-34.78
-74.12
75.60
69.87
-138.85
-24.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.42
-0.95
-0.64
-0.52
-0.43
-5.41
-0.41
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
127.39
-35.73
-74.76
75.08
69.44
-144.26
-24.86
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
741.56
613.95
649.15
723.77
648.40
578.63
706.93
Earnings per share (EPS)
0.14
-0.04
-0.08
0.09
0.08
-0.16
-0.03
Diluted Earnings per share
0.14
-0.04
-0.08
0.09
0.08
-0.16
-0.03
Operating Profit Margin (Excl OI)
37.18%
1.14%
-30.11%
38.98%
31.61%
-54.56%
-3.21%
Gross Profit Margin
30.06%
5.5%
-28.23%
49.11%
35.64%
-45.25%
13.18%
PAT Margin
42.73%
-12.28%
-55.44%
31.57%
22.66%
-64.59%
-20.46%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 5.61% vs 111.82% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 456.86% vs 52.27% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 180.81% vs 1,115.38% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -6.80% vs 10.62% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Hybio Pharmaceutical Co.. Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
299.15
0
299.15
Other Operating Income
0.00
0.00
0.00
Total Operating income
299.15
0
299.15
Raw Material Cost
105.01
0
105.01
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
23.28
0
23.28
Selling and Distribution Expenses
47.85
0
47.85
Other Expenses
0.76
0.00
0.76
Total Expenditure (Excl Depreciation)
183.73
0
183.73
Operating Profit (PBDIT) excl Other Income
115.41
0.00
115.41
Other Income
2.01
0
2.01
Operating Profit (PBDIT)
113.24
0
113.24
Interest
23.28
0
23.28
Exceptional Items
-0.05
0
-0.05
Gross Profit (PBDT)
194.13
0
194.13
Depreciation
0.00
0
0.00
Profit Before Tax
89.91
0
89.91
Tax
9.50
0
9.50
Provisions and contingencies
0
0
0.00
Profit After Tax
127.81
0
127.81
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
127.81
0
127.81
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.42
0
-0.42
Other related items
0.00
0.00
0.00
Consolidated Net Profit
127.39
0
127.39
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
741.56
0
741.56
Earnings per share (EPS)
0.14
0
0.14
Diluted Earnings per share
0.14
0
0.14
Operating Profit Margin (Excl OI)
37.18%
0%
0.00
37.18%
Gross Profit Margin
30.06%
0%
0.00
30.06%
PAT Margin
42.73%
0%
0.00
42.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 29.91 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 5.61% vs 111.82% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -2.98% vs 107.19% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 12.74 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 456.86% vs 52.27% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 83.57% vs 581.94% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.12 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 180.81% vs 1,115.38% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -14.85% vs 142.30% in Mar 2025
Quarterly - Interest
Interest 2.33 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -6.80% vs 10.62% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -7.54% vs -3.82% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.18%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
